MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
MediBeacon Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the ...
FDA Authorization of Flavored Zyn Products Ignores Appeal to Kids and Risks Another Juul
The FDA today has set a dangerous precedent that puts the nation's kids at risk by authorizing the sale of 20 Zyn nicotine ...
The FDA Continues to Intimidate Doctors and Defraud the American Public
HOUSTON, TEXAS / ACCESSWIRE / January 9, 2025 / The Golden Gift announced today that affordable plasma interventions can have significant health and economic benefits to prevent or manage age-related ...
Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review.
FDA Approves Lilly's Omvoh® (Mirikizumab-Mrkz) For Crohn's Disease, Expanding Its Use To The Second Major Type Of Inflammatory Bowel Disease
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...
Illuccix® Receives European Approval
Telix’s lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug ...
Carl Zeiss Meditec AG: ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with ...
AK Infinite: Copperprotek, The First Packaging Copper-Salts-Based Shelf Life Extension Additive, Announces FDA/FSIS Clearance
Copperprotek USA, the U.S.-based division of Copperprotek SpA, announced FDA/FSIS GRAS (Generally Recognized As Safe) approval of its patented microparticle.
4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path
NDAQ:FDMT) 4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path ...
Medindia3d
PreludeDx Receives FDA Breakthrough Device Designation for DCISionRT® Test for DCIS Breast Cancer Patients
Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...
verywellhealth7d
How to Find an Online Pharmacy You Can Trust
However, the concern that the VIPPS logo could be easily copied and used fraudulently ... An online pharmacy accredited by these organizations will be listed as an approved pharmacy on the NABP or FDA ...
Amneal receives FDA tentative approval for ANDA for rifaximin
The tentative approval for ANDA 218862 was posted to the Drugs@FDA site. Stay Ahead of the Market:Discover outperforming stocks and invest ...